BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ·Healthcare·Biotechnology
$8.95
+1.53%
Mkt Cap $2.48B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (15 analysts)
$20.00
Range $14.00 – $29.00
Implied Upside
+123.6%
Consensus $20.00 vs current $8.95
NASDAQ·Healthcare·Biotechnology
$8.95
+1.53%
Mkt Cap $2.48B
Buy
5
Hold
0
Sell
0
Price Target (15 analysts)
$20.00
Range $14.00 – $29.00
+123.6%
Consensus $20.00 vs current $8.95